Published in Women's Health Weekly, June 21st, 2001
Hundreds of patients are being sought to take part in three clinical trials to study the experimental anti-VEGF antibody (Avastin) in combination with chemotherapy on advanced breast and colorectal cancers. A product...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly